Patents by Inventor Yu-Hui Cheng
Yu-Hui Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240178211Abstract: A semiconductor device is provided. The semiconductor device comprises a first semiconductor die comprising a first capacitor, and a second semiconductor die in contact with the first semiconductor die and comprises a diode. The first semiconductor die and the second semiconductor die are arranged along a first direction, and a diode is configured to direct electrons accumulated at the first capacitor to a ground.Type: ApplicationFiled: February 5, 2024Publication date: May 30, 2024Inventors: HSIN-LI CHENG, SHU-HUI SU, YU-CHI CHANG, YINGKIT FELIX TSUI, SHIH-FEN HUANG
-
Patent number: 11973005Abstract: A method includes bonding a first package and a second package over a package component, adhering a first Thermal Interface Material (TIM) and a second TIM over the first package and the second package, respectively, dispensing an adhesive feature on the package component, and placing a heat sink over and contacting the adhesive feature. The heat sink includes a portion over the first TIM and the second TIM. The adhesive feature is then cured.Type: GrantFiled: August 3, 2021Date of Patent: April 30, 2024Assignee: Taiwan Semiconductor Manufacturing Co., Ltd.Inventors: Yu-Hsun Wang, Ping-Yin Hsieh, Pu Wang, Li-Hui Cheng, Szu-Wei Lu
-
Patent number: 11923352Abstract: A semiconductor device is provided. The semiconductor device comprises a first semiconductor die comprising a first capacitor, and a second semiconductor die in contact with the first semiconductor die and comprises a diode. The first semiconductor die and the second semiconductor die are arranged along a first direction, and a diode is configured to direct electrons accumulated at the first capacitor to a ground.Type: GrantFiled: January 28, 2022Date of Patent: March 5, 2024Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.Inventors: Hsin-Li Cheng, Shu-Hui Su, Yu-Chi Chang, Yingkit Felix Tsui, Shih-Fen Huang
-
Patent number: 8946208Abstract: A composition for intranasal delivery of a drug comprising: includes: (i) the drug; and (ii) a non-aqueous vehicle containing (a) propylene glycol and at least one additional solvent selected from N-methylpyrrolidone, propylene carbonate, dimethyl sulfoxide and at least one propylene glycol fatty acid ester; (b) from about 40 to 100% by volume of N-methylpyrrolidone; or (c) from about 40 to 100% by volume of dimethyl sulfoxide (DMSO).Type: GrantFiled: August 29, 2008Date of Patent: February 3, 2015Assignee: Archimedes Development LimitedInventors: Jonathan Castile, Alan Smith, Yu-Hui Cheng, Peter James Watts
-
Patent number: 8710028Abstract: A powder composition for intranasal delivery includes a benzodiazepine drug and chitosan, a salt of chitosan, a derivative of chitosan or a salt of a derivative of chitosan.Type: GrantFiled: August 29, 2008Date of Patent: April 29, 2014Assignee: Archimedes Development LimitedInventors: Peter James Watts, Yu-Hui Cheng, Alan Smith, Jonathan Castile
-
Patent number: 8481070Abstract: There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.Type: GrantFiled: September 30, 2009Date of Patent: July 9, 2013Assignee: Archimedes Development LimitedInventors: Ann Margaret Dyer, Peter James Watts, Yu-Hui Cheng, Alan Smith
-
Patent number: 8309108Abstract: A liquid aqueous formulation for the intranasal administration of apomorphine includes: (a) at least about 15 mg/ml of apomorphine; and (b) a solubilising agent selected from (i) at least one polyoxyethylene-polyoxypropylene copolymer (poloxamer); (ii) at least one cyclodextrin; and (iii) at least one cyclodextrin together with chitosan. The formulations of the invention can be used in the treatment or management of Parkinson's disease and erectile dysfunction.Type: GrantFiled: November 10, 2008Date of Patent: November 13, 2012Assignee: Archimedes Development LimitedInventors: Peter Watts, Yu-Hui Cheng
-
Patent number: 8034371Abstract: The present invention provides compositions for the intranasal administration of zolpidem or a pharmaceutically acceptable salt thereof. Preferred compositions of the invention are in the form of aqueous solutions. Optionally the compositions of the invention comprise a cyclodextrin and/or chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention insomnia or the treatment of neurological disorders such as those arising from brain trauma, stroke and spinocerebellar ataxia or in the treatment of Parkinson's disease.Type: GrantFiled: December 23, 2004Date of Patent: October 11, 2011Assignee: Archimedes Development LimitedInventors: Jonathan David Castile, Yu-Hui Cheng, Paul George Jenkins, Alan Smith, Peter James Watts
-
Publication number: 20100256091Abstract: A powder composition for intranasal delivery includes a benzodiazepine drug and chitosan, a salt of chitosan, a derivative of chitosan or a salt of a derivative of chitosan.Type: ApplicationFiled: August 29, 2008Publication date: October 7, 2010Applicant: ARCHIMEDES DEVELOPMENT LIMITEDInventors: Peter James Watts, Yu-Hui Cheng, Alan Smith, Jonathan Castile
-
Publication number: 20100249170Abstract: A liquid aqueous formulation for the intranasal administration of apomorphine includes: (a) at least about 15 mg/ml of apomorphine; and (b) a solubilising agent selected from (i) at least one polyoxyethylene-polyoxypropylene copolymer (poloxamer); (ii) at least one cyclodextrin; and (iii) at least one cyclodextrin together with chitosan. The formulations of the invention can be used in the treatment or management of Parkinson's disease and erectile dysfunction.Type: ApplicationFiled: November 10, 2008Publication date: September 30, 2010Applicant: ARCHIMEDES DEVELOPMENT LIMITEDInventors: Peter Watts, Yu-Hui Cheng
-
Patent number: 7662403Abstract: There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.Type: GrantFiled: January 4, 2006Date of Patent: February 16, 2010Assignee: Archimedes Development LimitedInventors: Ann Margaret Dyer, Peter James Watts, Yu-Hui Cheng, Alan Smith
-
Publication number: 20100021553Abstract: There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.Type: ApplicationFiled: September 30, 2009Publication date: January 28, 2010Applicant: ARCHIMEDES DEVELOPMENT LIMITEDInventors: Ann Margaret DYER, Peter James WATTS, Yu-Hui CHENG, Alan SMITH
-
Publication number: 20090233912Abstract: A composition for intranasal delivery of a drug comprising: includes: (i) the drug; and (ii) a non-aqueous vehicle containing (a) propylene glycol and at least one additional solvent selected from N-methylpyrrolidone, propylene carbonate, dimethyl sulfoxide and at least one propylene glycol fatty acid ester; (b) from about 40 to 100% by volume of N-methylpyrrolidone; or (c) from about 40 to 100% by volume of dimethyl sulfoxide (DMSO).Type: ApplicationFiled: August 29, 2008Publication date: September 17, 2009Applicant: ARCHIMEDES DEVELOPMENT LIMITEDInventors: Jonathan CASTILE, Alan SMITH, Yu-Hui CHENG, Peter James WATTS
-
Publication number: 20070140981Abstract: The present invention provides compositions for the intranasal administration of zolpidem or a pharmaceutically acceptable salt thereof. Preferred compositions of the invention are in the form of aqueous solutions. Optionally the compositions of the invention comprise a cyclodextrin and/or chitosan, a salt or derivative thereof or a salt of a derivative of chitosan. The compositions can be used for the treatment or prevention insomnia or the treatment of neurological disorders such as those arising from brain trauma, stroke and spinocerebellar ataxia or in the treatment of Parkinson's disease.Type: ApplicationFiled: December 23, 2004Publication date: June 21, 2007Applicant: ARCHIMEDES DEVELOPMENT LIMITEDInventors: Jonathan Castile, Yu-Hui Cheng, Paul Jenkins, Alan Smith, Peter Watts
-
Publication number: 20060120973Abstract: There is provided a powder formulation for nasal delivery including a protein having a molecular weight of 10 kDa or greater and chitosan or a derivative thereof or a salt of chitosan or a salt of a derivative of chitosan. Preferably the protein is human growth hormone.Type: ApplicationFiled: January 4, 2006Publication date: June 8, 2006Inventors: Ann Dyer, Peter Watts, Yu-Hui Cheng, Alan Smith
-
Publication number: 20050101688Abstract: A polymeric material applicable for making a data-recording layer of a multi-layer recording medium in the process using a plastic stamper is provided. In the manufacturing process of multi-layer recording media, a plastic substrate carrying data signals is used as a stamper. The stamper includes a plastic substrate formed thereon a signal-carrying layer. The polymeric material is applied on the plastic stamper to form a data-recording layer. The polymeric material has good duplicating characteristics and has different adhesion to a metallic layer and a polymeric layer so that data-recording layer made by the polymeric material is easy to be peeled off from the stamper. The stamper is also reusable for several times so as to save manufacturing cost.Type: ApplicationFiled: February 5, 2004Publication date: May 12, 2005Inventors: Wen-Yih Liao, Huei-Wen Yang, Ching-Yu Hsieh, Fu-Hsi Yu, Yu-Hui Cheng
-
Publication number: 20010051613Abstract: The present invention provides a composition comprising (i) fexofenadine or a pharmaceutically acceptable salt thereof and (ii) a pharmaceutical excipient that increases the solubility of the fexofenadine or salt in water. The pharmaceutical excipient is preferably a cyclodextrin.Type: ApplicationFiled: April 13, 2001Publication date: December 13, 2001Applicant: West Pharmaceutical Services Drug Delivery & Clinical Research Centre, Ltd.Inventors: Lisbeth Illum, Peter James Watts, Yu-Hui Cheng